Trial intelligence / Profile preview

Valproic Acid in Non-metastatic Prostate Cancer

NCT00670046Phase 2Terminated

Sponsor
Sidney Kimmel Comprehensive Cancer Center
Start
May 2008
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of valproic acid in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2008; status: terminated.

02

Drugs

valproic acid
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00670046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00670046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call